ÂÜÀòÂÒÂ×

Steve Tullman is the Managing Partner of NeXeption, a biopharmaceutical management company that brings together product opportunities, management expertise and the necessary funding to build biopharmaceutical companies focused on reaching compelling partnership milestones. He brings more than 25 years of biopharmaceutical global commercialization and drug development experience. Within the NeXeption portfolio companies, Steve is currently the Chairman of Aclaris Therapeutics, Chairman of Alexar Therapeutics and a founding partner of Celaris Therapeutics. He recently served as the CEO and Chairman of Ceptaris Therapeutics, acquired by Actelion in 2013.

Previously, Steve was Chairman of Vicept Therapeutics, acquired by Allergan in 2011. He was the Chief Executive Officer of Ception Therapeutics, acquired by Cephalon in 2010. He was also the Chief Business Officer and co-founder of Trigenesis, acquired by Dr. Reddy’s Laboratories in 2004. He started his career at SmithKline Beecham.